HAEMONETICS CORP - Common stock, $0.01 par value per share (HAE)

CUSIP: 405024100

Q1 2017 13F Holders as of 31 Mar 2017

Holder snapshot 6 signals
Share change
+8,304,395
SEC-reported price per share
$40.57
Indexed holders
176
Value change
+$337,134,900
Number of buys
91
Number of sells
77
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
45,420,621

Security key

405024100

Report period

Q1 2017

Indexed institutions

176

Top holders

10

Ownership snapshot

Top reported holders of HAE - HAEMONETICS CORP - Common stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
0/15
Latest evidence
31 Dec 2016
13F Highest disclosed value: $217,158,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PRICE T ROWE ASSOCIATES INC /MD/ has the largest disclosed position value at $217.16M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Disclosed position value Top 5
PRICE T ROWE ASSOCIATES INC /MD/ $217.16M
VANGUARD GROUP INC $175.36M
BlackRock Fund Advisors $166.32M
WELLINGTON MANAGEMENT GROUP LLP $137.42M
WELLS FARGO & COMPANY/MN $93.75M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$217,158,000
5,401,931 shares
— 31 Dec 2016
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$175,361,000
4,362,238 shares
— 31 Dec 2016
BlackRock Fund Advisors
13F
Company
13F
—
denominator unverified
$166,324,000
4,137,423 shares
— 31 Dec 2016
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$137,415,000
3,418,261 shares
— 31 Dec 2016
WELLS FARGO & COMPANY/MN
13F
Company
13F
—
denominator unverified
$93,746,000
2,331,992 shares
— 31 Dec 2016
VICTORY CAPITAL MANAGEMENT INC
13F
Company
13F
—
denominator unverified
$86,738,000
2,157,654 shares
— 31 Dec 2016
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
176
Shares
54,635,388
Indexed holders
176
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 indexed holders
192
Q1 2017 indexed holders
176
Indexed holder difference
-16
Investor Q4 2016 Shares Q1 2017 Shares Share Diff Share Chg % Q4 2016 value Q1 2017 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .